Orion Corporation (Finnish company)

This article is about the pharmaceutical company. For other companies named Orion, see Orion (disambiguation).

Orion Corporation
Native name
Orion Oyj
Company typeJulkinen osakeyhtiö
Nasdaq Helsinki: ORNAV, ORNBV
IndustryPharmaceutical industry
Founded21 September 1917; 107 years ago (1917-09-21)
HeadquartersEspoo, Finland
Key people
Liisa Hurme (President and CEO), Mikael Silvennoinen (Chairman)
ProductsPharmaceuticals and active pharmaceutical ingredients
RevenueDecrease €1.041 billion (2021)
Decrease €243.3 million (2021)
Decrease €193.8 million (2021)
Total assetsDecrease €1.114 billion (2021)
Total equityIncrease €747.9 million (2021)
Number of employees
Increase 3,364 (2021)
Websitewww.orion.fi/en
Footnotes / references
[1]

Orion Corporation (Finnish: Orion Oyj),[2][3] founded in 1917 and headquartered at Espoo, Finland, is a globally operating Finnish company which develops, manufactures and markets human and veterinary pharmaceuticals and active pharmaceutical ingredients for global markets. All of the company's manufacturing sites and the majority of its R&D units are in Finland.[4]

Orion's class A and B shares are listed on the Helsinki Stock Exchange.

  1. ^ https://www.orion.fi/globalassets/documents/orion-group/investors/interim-reports/2021/en_orion_fy_2021.pdf [bare URL PDF]
  2. ^ Cite error: The named reference bis_orion was invoked but never defined (see the help page).
  3. ^ Cite error: The named reference orion_bylaws was invoked but never defined (see the help page).
  4. ^ "About Orion".